Dublin, April 05, 2017 -- Research and Markets has announced the addition of the "Global Heart Valve Devices Market: Analysis By Procedure, Replacement Procedure By Technique, Repair Procedure By Technique, By Region, By Country (2016-2021)" report to their offering.
Global Heart Valve Devices Market is forecasted to grow at a CAGR of 13.35% during 2016-2021. The strong growth in heart valve devices is driven by rising aging population, growth in population with heart disease and rising advances in minimally invasive technologies. Moreover, companies operating in this market are focusing on investments in R&D for continuous innovation and strengthening their positions in the market by targeted acquisitions and product expansions. Edwards Lifesciences, Medtronic, Abbott Laboratories and Boston Scientific are the major players in the market.
Demand for bioprosthetic is projected to display a faster growth than mechanical heart valve replacement techniques. However, technologically advanced techniques such as TAVR and TMVR are going to be the major growing sectors in the market. Among the regions, APAC is predicted to advance at the highest rate, mainly driven by the rising number of geriatric population, growing healthcare infrastructure and expansion in medical tourism.
Scope of the Report
The report provides coverage by Procedure, Technique, Region and Country:
By Procedure:
- Heart Valve Replacement Devices
- Heart Valve Repair Devices
Heart Valve Replacement Devices, By Technique:
- Mechanical Valve
- Bioprosthetic Valve
- TAVR (Transcatheter Aortic Valve Replacement)
Heart Valve Repair Devices, By Technique:
- Surgical Valve Repair Devices
- Balloon Valvuloplasty Devices
- TMVR (Transcatheter Mitral Valve Repair)
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
3.1 Increasing demand for Bioprosthetic Valve replacement techniques
3.2 Rapid transition towards Transcatheter Heart Valve therapies
3.3 Asia Pacific Region to witness the fastest growth in Heart Valve Devices Market in the forecast period
4. Heart Valve Devices Outlook
5. Global Heart Valve Devices Market: Growth and Forecast
6. Global Heart Valve Devices Market-By Procedure
7. Global Heart Valve Replacement Devices: By Technique
8. Global Heart Valve Devices Market: Regional Analysis
9. Market Dynamics
10. Market Trends
11. Porter's Five Forces Analysis - Heart Valve Devices Market
12. SWOT Analysis -Heart Valve Devices Market
13. Supply Chain Analysis
14. Competitive Landscape
14.1 Global Heart Valve Devices Market- Country Pricing and Volume Analysis (U.S., Germany, France, India)
14.2 Global Heart Valve Devices Market- Company Share Analysis
14.3 Product Benchmarking of Key Industry Players, By Procedure
14.4 Product Benchmarking of Key Industry Players in Heart Valve Replacement Procedure, By Technique
15. Policy and Regulatory Landscape
16. Company Profiles
- Abbott Laboratories
- Boston Scientific Corporation
- CryoLife Inc.
- Edwards Lifesciences Corporation
- JenaValve Technology Inc.
- LivaNova Plc
- Medtronic Plc
- Meril Life Sciences Pvt. Ltd.
- Neovasc Inc.
- St. Jude Medical Inc.
- TTK Healthcare
For more information about this report visit http://www.researchandmarkets.com/research/d787fw/global_heart
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Devices


AFT Leaves X Over AI-Generated Images of Minors
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures 



